Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis

Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis

Abstract COVID-19 patients with acute hypoxemic respiratory failure (AHRF) benefit from high flow nasal cannula (HFNC) oxygen therapy. However, delays in initiating invasive ventilation after HFNC failure are associated with poorer outcomes. The respiratory oxygenation (ROX) index, combining SpO2/Fi...

Full description

Bibliographic Details
Main Authors: Chun En Yau, Dawn Yi Xin Lee, Adithi Vasudevan, Ken Junyang Goh, Evelyn Wong, Andrew Fu Wah Ho, Daniel Yan Zheng Lim
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Critical Care
Subjects:
ROX index
COVID-19
High flow nasal cannula
Systematic review
Meta-analysis
Respiratory failure
Online Access:https://doi.org/10.1186/s13054-023-04567-7

Internet

https://doi.org/10.1186/s13054-023-04567-7

Similar Items